Abstract
Soluble ADA is known to occur in different isozymes in man. Two major forms have been identified in the normal human tissues: the so called red cell ADA or ADA-S, a monomeric protein, with a M.W. of about 35KD (kilodaltons), and a tissue specific form, or ADA-L, of about 300KD, composed of a dimeric glycoprotein molecule (adenosine deaminase complexing protein=ADCP) and two molecules ADA-S. Additional ADA isozymes have been reported by several authors: a form of 435KD in the normal intestine, a so called particulate form in different tissues probably due to membrane bound ADA4 and a cancer specific 70KD in some colorectal tumors5. Nishihara et al.6 observed that free ADCP, usually present in normal lung tissue, was strongly decreased in the extracts of cancerous lung. Trotta and Balis presented evidence for the absence of ADCP in a clear cell carcinoma of the kidney, in spite of the fact that normal kidney is the major source of free ADCP. In the same report they described a striking decrease of ADA-L, thus of ADCP, in 14 out of 15 colorectal tumors. These data and the data presented by Herbschleb-Voogt et al. (this conference), where ADA-L was found to be almost absent or markedly decreased in 6 transformed- and tumor derived cell lines, formed the basis for the present investigation.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
PE Daddona, WN Kelley, Mol Cell Biochem, 29: 91 (1980)
YH Edwards, DA Hopkinson, Ann Hum Genet, 35: 207 (1971)
MB van der Weyden, WN Kelley, J Biol Chem, 251: 5448 (1976)
WP Schrader, PJ Bryer, Arch Biochem Bioph, 215: 107 (1982)
PP Trotta, ME Balis, Biochemistry, 17: 270 (1978)
H Nishihara, S Ishikawa, K Shinkai, H Akedo, Biochim Biophys Acta, 302: 429 (1973)
Jten Kate, J Th Wijnen, E Herbschleb-Voogt, G Griffioen, FT Bosnian, P Meera Khan, in press, in: “Progress in Clin Enzymology, Vol 2”
PE Daddona, WN Kelley, J Biol Chem, 253: 4617 (1978)
BE Chechik, A Madapallimattam, EW Gelfand, J Natl Cancer Inst, 62: 465 (1979)
PE Daddona, MA Frohman, WN Kelley, J Clin Invest, 64: 98 (1979)
OH Lowry, NJ Rosebrough, AL Farr, RJ Randall, J Biol Chem, 193: 265 (1951)
DA Hopkinson, PJL Cook, H Harris, Ann Hum Genet, 32: 361 (1969)
FT Bosnian, JWK Louwerens, Am J Pathol, 104: 174 (1981)
LP Rutzky, MJ Siciliano, J Natl Cancer Inst, 68: 81 (1982)
WP Schrader, B Pollara, J Lab Clin Med, 92: 656 (1978)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer Science+Business Media New York
About this chapter
Cite this chapter
ten Kate, J., Wijnen, J.T., Herbschleb-Voogt, E., Griffioen, G., Bosman, F.T., Khan, P.M. (1984). Adenosine Deaminase (ADA; E.C. no. 3.5.4.4.) in Colorectal Adenocarcinoma in Man. In: De Bruyn, C.H.M.M., Simmonds, H.A., Müller, M.M. (eds) Purine Metabolism in Man-IV. Advances in Experimental Medicine and Biology, vol 165. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-0390-0_57
Download citation
DOI: https://doi.org/10.1007/978-1-4757-0390-0_57
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-0392-4
Online ISBN: 978-1-4757-0390-0
eBook Packages: Springer Book Archive